DGAP-News: Evotec SE / Key word(s): Miscellaneous06.04.2020 / 07:00 The issuer is solely responsible for the content of this announcement. EVOTEC ESTABLISHES GENE THERAPY R&D SITE WITH MORE THAN 20 EXPERIENCED SCIENTISTS IN AUSTRIA BECOMING FULLY MODALITY AGNOSTIC WITH EXPANSION INTO ...
DGAP-News: Evotec SE / Key word(s): Miscellaneous06.04.2020 / 07:00 The issuer is solely responsible for the content of this announcement. EVOTEC ESTABLISHES GENE THERAPY R&D SITE WITH ...
DGAP-News: Evotec SE / Key word(s): Miscellaneous06.04.2020 / 07:15 The issuer is solely responsible for the content of this announcement. TAKEDA LEVERAGES EVOTEC'S NEW GENE THERAPY UNIT TO ...
Advances in cell and gene therapies (CGT) offer the potential to transform medicine. They create an inflection point in the ability to treat and potentially cure many intractable illnesses. ...
CRISPR, capacity, and consolidation powered the cell and gene therapy space in 2019, but a proactive focus on patient access topped the annual roundup
CRISPR, capacity, and consolidation powered the cell and gene therapy space in 2019, but a proactive focus on patient access topped Falcon Therapeutics
/PRNewswire/ -- The Discovery Labs and Deerfield Management Company have formed The Center for Breakthrough Medicines, a Contract Development and Manufacturing...
Having launched near the beginning of the last decade, Toronto-based CCRM has had a ringside seat to the noteworthy advances in our industry —...
In December, Novartis posted a letter to the spinal muscular atrophy community, announcing a plan for a global managed access program to provide its gene therapy Zolgensma at no cost to ...